Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degenerationJennifer Gass, Rosa Rademakers, Ashley Cannon et al.|Human Molecular Genetics|2006Cited by 578
CSF biomarker variability in the Alzheimer's Association quality control programNiklas Mattsson, Olivier Bousiges, Ulf Andréasson et al.|Alzheimer s & Dementia|2013Cited by 386
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s diseaseStephen Salloway, Paul Aisen, Chengjie Xiong et al.|Nature Medicine|2021Cited by 365
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiativeRosa Rademakers, Mike Hutton, Matt Baker et al.|The Lancet Neurology|2007Cited by 217
Amyloid‐Related Imaging Abnormalities in the <scp>DIAN‐TU</scp>‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer DiseaseNelly Joseph‐Mathurin, Richard J. Perrin, Jorge J. Llibre‐Guerra et al.|Annals of Neurology|2022Cited by 42